TransEnterix, Inc. (TRXC): Price and Financial Metrics
TRXC Price/Volume Stats
| Current price | $4.08 | 52-week high | $6.95 |
| Prev. close | $4.54 | 52-week low | $0.28 |
| Day low | $3.62 | Volume | 37,554,300 |
| Day high | $4.77 | Avg. volume | 44,558,918 |
| 50-day MA | $3.04 | Dividend yield | N/A |
| 200-day MA | $1.09 | Market Cap | 582.53M |
TRXC Stock Price Chart Interactive Chart >
TransEnterix, Inc. (TRXC) Company Bio
TransEnterix, Inc. focuses on the development and commercialization of a robotic assisted surgical system in the United States and internationally. The company is based in Morrisville, North Carolina.
Latest TRXC News From Around the Web
Below are the latest news stories about Transenterix Inc that investors may wish to consider to help them evaluate TRXC as an investment opportunity.
Asensus Surgical, Inc. Schedules Fourth Quarter and Fiscal Year 2020 Financial and Operating Results Conference Call for March 11, 2021Asensus Surgical, Inc. (NYSE American: TRXC) (formerly TransEnterix, Inc.), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release fourth quarter and fiscal year 2020 financial and operating results after the market closes on Thursday, March 11, 2021. The Company will host a conference call to discuss these results starting at 4:30 p.m. ET the same day. The call will be concurrently webcast. |
Asensus Surgical Announces FDA Clearance in General SurgeryAsensus Surgical, Inc. (formerly TransEnterix, Inc.) (NYSE American: TRXC) , a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, today announced the Company has received an additional FDA clearance for the Senhance Surgical System which allows for indication expansion in general surgery in the United States. |
TransEnterix (TRXC) Flat As Market Gains: What You Should KnowTransEnterix (TRXC) closed at $3.72 in the latest trading session, marking no change from the prior day. |
Asensus Surgical to Present at the H.C. Wainwright Virtual Global Life Sciences ConferenceAsensus Surgical, Inc. (NYSE American: TRXC) (formerly TransEnterix, Inc.), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery, announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the H.C. Wainwright Virtual Global Life Sciences Conference taking place March 9 and March 10, 2021. |
Is TransEnterix a Good Stock to Buy Now?Shares of the robotic surgical-system manufacturer are soaring, but can this company become the next Intuitive Surgical? |
TRXC Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | -51.47% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | 0.00% |
| 2020 | -57.48% |
| 2019 | -95.00% |
Continue Researching TRXC
Want to do more research on Transenterix Inc's stock and its price? Try the links below:Transenterix Inc (TRXC) Stock Price | Nasdaq
Transenterix Inc (TRXC) Stock Quote, History and News - Yahoo Finance
Transenterix Inc (TRXC) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...